These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37722463)

  • 61. Aortitis is an under-recognized manifestation of antiphospholipid syndrome: A case report and literature review.
    Escoda T; George J; Jarrot PA; Jean R; Mazodier K; Sanderson F; Poullin P; Saby L; Jourde-Chiche N; Kaplanski G; Chiche L
    Lupus; 2022 May; 31(6):744-753. PubMed ID: 35341372
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Autoimmune haemolytic anaemia and thrombocytopaenia in a single-centre cohort of patients with systemic lupus erythematosus from Turkey: clinical associations and effect on disease damage and survival.
    Artım-Esen B; Çene E; Şahinkaya Y; Erdugan M; Oğuz E; Gül A; Öcal L; İnanç M
    Lupus; 2019 Oct; 28(12):1480-1487. PubMed ID: 31558101
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Relentless Recurrence of Diffuse Alveolar Hemorrhage in Catastrophic Antiphospholipid Syndrome and Lupus: A Therapeutic Challenge.
    Rahman A; Nathani M; Malekan M
    Cureus; 2024 Jun; 16(6):e62635. PubMed ID: 38898898
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rheumatic diseases associated with alveolar hemorrhage: analysis of the national inpatient sample.
    Kambhatla S; Vipparthy S; Manadan AM
    Clin Rheumatol; 2023 Apr; 42(4):1177-1183. PubMed ID: 36396790
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epidemiology, Risk Factors, and Outcomes of Diffuse Alveolar Hemorrhage After Hematopoietic Stem Cell Transplantation.
    Zhang Z; Wang C; Peters SG; Hogan WJ; Hashmi SK; Litzow MR; Patnaik MS; Niven AS; Yadav H
    Chest; 2021 Jun; 159(6):2325-2333. PubMed ID: 33434501
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome.
    Krause I; Blank M; Fraser A; Lorber M; Stojanovich L; Rovensky J; Shoenfeld Y
    Immunobiology; 2005; 210(10):749-54. PubMed ID: 16325493
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome.
    Crausman RS; Achenbach GA; Pluss WT; O'Brien RF; Jennings CA
    J Rheumatol; 1995 Mar; 22(3):554-6. PubMed ID: 7783081
    [TBL] [Abstract][Full Text] [Related]  

  • 68. French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children.
    Amoura Z; Bader-Meunier B; Bal Dit Sollier C; Belot A; Benhamou Y; Bezanahary H; Cohen F; Costedoat-Chalumeau N; Darnige L; Drouet L; Elefant E; Harroche A; Lambert M; Martin T; Martin-Toutain I; Mathian A; Mekinian A; Pineton De Chambrun M; de Pontual L; Wahl D; Yelnik C; Zuily S;
    Rev Med Interne; 2023 Sep; 44(9):495-520. PubMed ID: 37735010
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus. Clinical manifestations, treatment, and prognosis.
    Martínez-Martínez MU; Abud-Mendoza C
    Reumatol Clin; 2014; 10(4):248-53. PubMed ID: 24704107
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome.
    Stoots SA; Lief L; Erkan D
    Curr Rheumatol Rep; 2019 Sep; 21(10):56. PubMed ID: 31493005
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities.
    Sciascia S; Murru V; Sanna G; Roccatello D; Khamashta MA; Bertolaccini ML
    J Thromb Haemost; 2012 Dec; 10(12):2512-8. PubMed ID: 23025466
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bleeding in the antiphospholipid syndrome.
    Forastiero R
    Hematology; 2012 Apr; 17 Suppl 1():S153-5. PubMed ID: 22507807
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Extra-criteria manifestations of antiphospholipid syndrome: Risk assessment and management.
    Radin M; Ugolini-Lopes MR; Sciascia S; Andrade D
    Semin Arthritis Rheum; 2018 Aug; 48(1):117-120. PubMed ID: 29395258
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diffuse alveolar haemorrhage in systemic lupus erythematosus: A multicentre retrospective study in Singapore.
    Law AH; Chuah TY; Lee W; Teng GG; Lian TY; Saffari SE; Chew LC
    Lupus; 2023 Jul; 32(8):952-963. PubMed ID: 37268601
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vascular- and pregnancy-related outcomes in patients with systemic lupus erythematosus with positive antiphospholipid profile and thrombocytopenia.
    Haddad A; Gladman DD; Ibañez D; Urowitz MB
    Lupus; 2015 Jul; 24(8):822-6. PubMed ID: 25542904
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Characteristics and Prognosis of Microscopic Polyangiitis Patients with Diffuse Alveolar Hemorrhage and Interstitial Lung Disease.
    Gu Y; Zhang T; Peng M; Shi JH
    Chin Med Sci J; 2022 Dec; 37(4):293-302. PubMed ID: 36000390
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus.
    Drenkard C; Villa AR; Alarcón-Segovia D; Pérez-Vázquez ME
    J Rheumatol; 1994 Jun; 21(6):1067-72. PubMed ID: 7932417
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In-Hospital Mortality-Associated Factors in Patients With Thrombotic Antiphospholipid Syndrome Requiring ICU Admission.
    Pineton de Chambrun M; Larcher R; Pène F; Argaud L; Mayaux J; Jamme M; Coudroy R; Mathian A; Gibelin A; Azoulay E; Tandjaoui-Lambiotte Y; Dargent A; Beloncle FM; Raphalen JH; Couteau-Chardon A; de Prost N; Devaquet J; Contou D; Gaugain S; Trouiller P; Grangé S; Ledochowski S; Lemarie J; Faguer S; Degos V; Luyt CE; Combes A; Amoura Z
    Chest; 2020 May; 157(5):1158-1166. PubMed ID: 31783015
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Features associated with epilepsy in the antiphospholipid syndrome.
    Shoenfeld Y; Lev S; Blatt I; Blank M; Font J; von Landenberg P; Lev N; Zaech J; Cervera R; Piette JC; Khamashta MA; Bertolaccini ML; Hughes GR; Youinou P; Meroni PL; Pengo V; Alves JD; Tincani A; Szegedi G; Lakos G; Sturfelt G; Jönsen A; Koike T; Sanmarco M; Ruffatti A; Ulcova-Gallova Z; Praprotnik S; Rozman B; Lorber M; Chapman J; van-Breda-Vriezman PJ; Damoiseaux J
    J Rheumatol; 2004 Jul; 31(7):1344-8. PubMed ID: 15229954
    [TBL] [Abstract][Full Text] [Related]  

  • 80. How I treat anticoagulant-refractory thrombotic antiphospholipid syndrome.
    Cohen H; Isenberg DA
    Blood; 2021 Jan; 137(3):299-309. PubMed ID: 32898856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.